We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACER
13326
PUT
DELISTED
Acer Therapeutics Inc
ACER
$32K ﹤0.01%
+11,300
New +$32.5K
IMV
13327
DELISTED
IMV Inc. Common Shares
IMV
$32K ﹤0.01%
+1,454
New +$37K
TMBR
13328
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$32K ﹤0.01%
532
+21
+4% +$1.48K
GMBTW
13329
DELISTED
Pivotal Holdings Corp Warrant
GMBTW
$32K ﹤0.01%
31,375
-29
-0.1% -$27
CHGA
13330
Change Agents Corporation Common Stock
CHGA
$2.8M
$31K ﹤0.01%
211
+33
+19% +$5.26K
CNET icon
13331
ZW Data Action Technologies
CNET
$4.73M
$31K ﹤0.01%
784
-3,919
-83% -$151K
ENVB icon
13332
Enveric Biosciences
ENVB
$6.16M
$31K ﹤0.01%
+1
New +$21.4K
IFRX icon
13333
PUT
InflaRx
IFRX
$300M
$31K ﹤0.01%
+10,600
New +$35.2K
TOUR
13334
Tuniu
TOUR
$53.2M
$31K ﹤0.01%
1,315
-8,008
-86% -$219K
CSCI
13335
PUT
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$31K ﹤0.01%
356
+40
+13% +$3.8K
UAMY icon
13336
CALL
United States Antimony
UAMY
$825M
$30K ﹤0.01%
+30,200
New +$28K
WINT
13337
DELISTED
Windtree Therapeutics
WINT
-1
Closed -$97.3K
NVOS
13338
DELISTED
Novo Integrated Sciences, Inc. Common Stock
NVOS
$30K ﹤0.01%
+1,179
New +$29.4K
NH
13339
CALL
DELISTED
NantHealth, Inc
NH
$30K ﹤0.01%
867
-1,266
-59% -$50.3K
ONCS
13340
DELISTED
OncoSec Medical Incorporated
ONCS
$30K ﹤0.01%
481
-333
-41% -$30.2K
ABEO icon
13341
CALL
Abeona Therapeutics
ABEO
$341M
$29K ﹤0.01%
744
-696
-48% -$28.4K
AMBO
13342
Ambow Education Holding
AMBO
$6.09M
$29K ﹤0.01%
1,200
-1,410
-54% -$31.9K
AIXC
13343
PUT
AIxCrypto Holdings Inc
AIXC
$13.7M
$29K ﹤0.01%
29
-789
-96% -$800K
QTT
13344
CALL
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$29K ﹤0.01%
1,540
-5,800
-79% -$122K
NVSAW
13345
DELISTED
New Vista Acquisition Corp. Warrant
NVSAW
$29K ﹤0.01%
+29,333
New +$26.2K
ZVO
13346
CALL
DELISTED
Zovio Inc. Common Stock
ZVO
$29K ﹤0.01%
11,200
-15,400
-58% -$47.1K
BRCN
13347
DELISTED
Burcon NutraScience Corporation
BRCN
$29K ﹤0.01%
+10,540
New +$33.7K
DXF
13348
Eason Technology Ltd
DXF
$1.64M
$28K ﹤0.01%
14
-50
-78% -$103K
ITP icon
13349
CALL
IT Tech Packaging
ITP
$2.91M
$28K ﹤0.01%
5,950
-660
-10% -$3.38K
JOB icon
13350
GEE Group
JOB
$27M
$28K ﹤0.01%
+48,287
New +$32.2K

Similar funds

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.